-
-
-
-
-
-
-
Prelude Therapeutics (PRLD) PT Raised to $10 at Jefferies
-
-
-
-
-
-
-
Prelude Therapeutics gets FDA clearance for JAK2 inhibitor trial
-
-
-
-
-
-
-
Prelude Therapeutics Incorporated (PRLD) Tops Q2 EPS by 7c
-
-
-
-
-
-
-
H.C. Wainwright Upgrades Prelude Therapeutics (PRLD) to Buy, 'attractive entry point'
-
-
-
-
-
-
460,988 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

